Gene · 51547
Papers2,721
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,721
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Sirtuins in Thyroid Cancer: Mechanisms, Drug Development, and Emerging Roles in Tumor Immunity and Ferroptosis. | Cancers (Basel) | 2026 | 42449637 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis reveals tumor-suppressive phenotypes and associated transcriptomic remodeling upon METTL3 overexpression in A549 lung cancer cells. | Transl Cancer Res | 2026 | 42445413 | PubTator, text mining | PubMed |
| The Sirtuin Network: Linking NAD+ Metabolism, Mitochondrial Function, and Metabolic Homoeostasis. | Diabetes Metab Res Rev | 2026 | 42442718 | PubTator, text mining | PubMed |
| Epigenetic maintenance of male reproductive longevity: SIRT7 as a guardian of male germline genome integrity†. | Biol Reprod | 2026 | 42434895 | PubTator, text mining | PubMed |
| Deacetylation of SRF catalyzed by SIRT7 protects against abdominal aortic aneurysm formation. | Exp Mol Med | 2026 | 42420530 | PubTator, text mining | PubMed |
| Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle. | Oncogene | 2026 | 42387058 | PubTator, text mining | PubMed |
| Emerging roles of SIRT7 in metabolic homeostasis and related disorders. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42385862 | PubTator, text mining | PubMed |
| SIRT7-mediated ACSL3 delactylation suppresses colorectal cancer progression by orchestrating tumor-associated macrophage ferroptosis and polarization. | Cell Death Dis | 2026 | 42380090 | PubTator, text mining | PubMed |
| The Ageing Adipose Paradox: Implications for Metabolic Health. | Diabetes Obes Metab | 2026 | 42366180 | PubTator, text mining | PubMed |
| Chromatin chronicles: Unlocking the therapeutic potential of histone modifiers in hepatocellular carcinoma. | Med Oncol | 2026 | 42360649 | PubTator, text mining | PubMed |
| Sirtuins in Medicine: Multifaceted Roles in Physiological Processes and Cardiovascular Diseases. | Biomolecules | 2026 | 42352261 | PubTator, text mining | PubMed |
| Carvacrol-Based Formulations Modulate Sirtuins and Exert Cytotoxic and Antimicrobial Effects in Lung Cancer Models. | Antioxidants (Basel) | 2026 | 42352025 | PubTator, text mining | PubMed |
| ATAD2 suppresses senescence and SASP via SIRT7-p53/p21 to drive progression and immune evasion in endometrial cancer. | Clin Epigenetics | 2026 | 42324545 | PubTator, text mining | PubMed |
| The protective role of SIRT1 in cardiovascular disease: from molecular mechanisms to potential therapeutic strategies. | Expert Opin Ther Targets | 2026 | 42289992 | PubTator, text mining | PubMed |
| SIRT7 Inhibits Adipose Tissue Browning Through Deacetylation of PPARγ2 at K382. | Cells | 2026 | 42274620 | PubTator, text mining | PubMed |
| Deacetylated PCBP1 licenses PARP1 activity for DNA damage repair. | Mol Cell | 2026 | 42225061 | PubTator, text mining | PubMed |
| The Progression of Cardiac Damage in the Offspring of Mothers with Gestational Diabetes Is Regulated by the p53/miR-34/SIRT1/7 Pathway. | Int J Mol Sci | 2026 | 42196347 | PubTator, text mining | PubMed |
| Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications. | Front Immunol | 2026 | 42183207 | PubTator, text mining | PubMed |
| SIRT7-mediated deacetylation of XRCC6 at lysine 591 drives breast cancer progression. | Front Oncol | 2026 | 42180130 | PubTator, text mining | PubMed |
| A review of the sirtuins family: pivotal regulators and emerging therapeutic targets in renal fibrosis. | Ren Fail | 2026 | 42135894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51547/papers?page=2